A Behavioral Intervention for Depression and Chronic Pain in Primary Care

Not Applicable

Completed

• Conditions: Chronic Pain; Depression
• Interventions: Behavioral: RELIEF

• Registration Number: NCT03265210
• Lead Sponsor: Weill Medical College of Cornell University

Brief Summary

Chronic pain and depression frequently co-exist in late and mid-life and contribute to increased disability, high health care costs, psychiatric comorbidity, and suicide. The investigators will recruit 60 adults from Weill Cornell Medical Associates primary care practices; participants will be randomized to either Relief (a 9 session behavioral intervention) or usual care/referral for mental health care. Research assessments are conducted with both groups at study entry (Baseline), 6, 9, and 12 weeks.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2017-08-10
• Study First Submitted QC: 2017-08-28
• Study First Posted: 2017-08-29
• Study Start: 2018-02-01
• Primary Completion: 2022-02-22
• Study Completion: 2022-02-22
• Results First Submitted: 2023-01-26
• Results First Submitted QC: 2023-01-26
• Results First Posted: 2023-02-24
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-01
• Last Update Posted: 2023-03-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 73

Inclusion Criteria

• Age 50 years
• PHQ-9 greater than or equal to 10
• Non-cancer related chronic pain, defined as pain during most days over the past 3 months by patient report
• Capacity to consent

Read More

Exclusion Criteria

• DSM-5 Axis 1 other than depression and anxiety disorders
• Montreal Cognitive Assessment (MoCA) < 24
• Active suicidal ideation, i.e. MADRS Suicide Item greater than or equal to 4
• Severe or life-threatening medical illness.
• Patients on psychotropics, opioids or benzodiazepines will be included if they do not meet DSM-5 criteria for opioid, anxiolytics or other substance abuse disorders

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Relief	RELIEF	Relief relies on a neurobiological model to simplify its behavioral targets and uses mobile technology to augment its interventions. Relief was co-developed with our primary care partners with the goal to be usable by non-physician clinicians of primary care offices eligible to provide billable services.

Primary Outcome Measures

Name	Time	Method
Client Satisfaction Questionnaire (CSQ)	12 weeks	A questionnaire that evaluates participants' satisfaction with treatment; ranging from 1 (needs have not been met/dissatisfied) to 4 (almost all needs have been met/very satisfied).; Domain 1 measures met needs. Scores range from 0-4 and higher scores indicate more needs met. Domain 2 measures satisfaction with services. Scores range from 0-4 and higher scores indicate more satisfaction with services. Domain 3 measures willingness to return. Scores range from 0-4 and higher scores indicate greater willingness to return.
Change in Clinically Significant Depressive Symptoms, as Measured by the Montgomery Asberg Depression Rating Scale (MADRS)	Baseline, 6, 9, and 12 weeks	The MADRS is a 10 item questionnaire assessing severity of depression by scoring participants on mood, anxiety, sleep, concentration, appetite, and suicidal thoughts. The lowest score is 0, no depression symptoms, and the highest possible score is 60, severe depression symptoms.
Change in Pain-related Disability, as Measured by the Roland-Morris Disability Questionnaire (RMDQ)	Baseline, 6, 9, and 12 weeks	The RMDQ includes a scale assessing how much pain the participant has experienced in the past week, with 0 indicating no pain and 10 indicating pain as bad as he/she can imagine; scores will be listed under domain 1. In addition, the RMDQ also includes a series of questions related to pain disability, with 0 indicating no pain-related disability, and 24 indicating severe pain-related disability; scores will be listed under domain 2.

Secondary Outcome Measures

Name	Time	Method
Change in Mood, as Measured by the Daily Photographic Affect Meter (PAM)	Daily for 12 weeks	The PAM is used for assessing mood and emotional state. Participants can either score a "positive" or "negative" affect value. PAM uses photos that user selects and map it to arousal (y-axis) and valence(x-axis). Domain 1 is derived from PAM using y-axis (column score): (low activation to high activation): takes on discrete values ranging from 1 - 5. Domain 2 is derived from PAM using x-axis (row score): (unpleasurable to pleasurable or negative to positive): takes on discrete values ranging from 1 - 4.
Activities Monitoring	Daily for 12 weeks	Activities monitoring through a phone application; measuring number of places visited daily during the week. Data is based on the total uptime of the location stream (unit is continuous seconds).

Trial Locations

Locations (3)

Weill Cornell Internal Medicine Associates (WCIMA); 🇺🇸 New York, New York, United States

Iris Cantor Men's & Women's Health Centers; 🇺🇸 New York, New York, United States

Irving Sherwood Wright Center; 🇺🇸 New York, New York, United States